Matrix metalloproteinas-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease

Molecular Biology Reports

Volumn 39, Issue 1, 2012, Pages 555-562

  Saedi, Massoud ^a   Vaisi Raygani, Asad ^a,b,c   Khaghani, Shahnaz ^a   Shariftabrizi, Ahmad ^a   Rezaie, M ^a   Pasalar, Parvin ^a   Rahimi, Zohreh ^c   Pourmotabbed, Tayebeh ^a,d  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Early coronary artery disease; Genetic polymorphism; Homocysteine; Lipid profile; MMP 9; MMP 9 activity

Indexed keywords

CHOLESTEROL; GELATINASE B; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID; LIPOPROTEIN; PRIMER DNA;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HUMAN; IRAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 9 GENE; MOLECULAR PATHOLOGY; ONSET AGE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; AGED; ANALYSIS OF VARIANCE; BLOOD; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY ARTERY DISEASE; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HOMOCYSTEINE; HUMANS; IRAN; LIPIDS; LIPOPROTEINS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84855193033     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0770-x     Document Type: Article

References (37)

1. H Kharrazi A Vaisi Raygani AR Sabokroh T Pourmotabedd 2006 Association between apolipoprotein E polymorphism in coronary artery disease patients in Kermanshah, in west of Iran Clin Biochem 39 613 616 16545358 10.1016/j.clinbiochem.2006.02.002 1:CAS:528:DC%2BD28XmtVOhtrY%3D
2. A Vaisi-Raygani H Tavilani Z Rahimi M Zahrai N Sheikh M Aminian T Pourmotaabed 2009 Serum butyrylcholinesterase activity and phenotype associations with lipid profile in stroke patients Clin Biochem 42 210 214 19028482 10.1016/j.clinbiochem.2008.10.025 1:CAS:528:DC%2BD1MXhtFeku7s%3D
3. A Vaisi-Raygani Z Rahimi H Nomani H Tavilani T Pourmotaabed 2007 The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in Type 2 diabetic patients Clin Biochem 40 1150 1156b 17689519 10.1016/j.clinbiochem.2007.06.010 1:CAS:528:DC%2BD2sXhtVWms7vN (Pubitemid 47379326)
4. S Abilleira S Bevan HS Markus 2006 The role of genetic variants of matrix metalloproteinases in coronary and carotid atherosclerosis J Med Genet 43 897 901 16905683 10.1136/jmg.2006.040808 1:CAS:528:DC%2BD2sXhtVOgsbk%3D (Pubitemid 46080185)
5. A Vaisi-Raygani Z Rahimi H Tavilani T Pourmotaabed 2010 Butyrylcholinesterase K variant and the APOE-e4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients Mol Biol Rep 37 2083 2091 19685167 10.1007/s11033-009-9666-4 1:CAS:528: DC%2BC3cXis1Wls7g%3D
6. Y Li DL Sun YN Duan XJ Zhang N Wang RM Zhou ZF Chen SJ Wang 2010 Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China Mol Biol Rep 37 1 197 205 19562509 10.1007/s11033-009-9593-4 1:CAS:528:DC%2BC3cXisFSlsg%3D%3D
7. AR Morgan B Zhang W Tapper A Collins S Ye 2003 Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease J Mol Med 81 321 326 12728308 1:CAS:528:DC%2BD3sXjvVSltrc%3D (Pubitemid 36718329)
8. Rahimi Z, Vaisi-Raygani A, Pourmotaabed T (2011) Association between apolipoprotein ε4 allele, factor V Leiden, and plasma lipid and lipoprotein levels with sickle cell disease in Southern Iran. Mol Biol Rep 38(2):703-710
9. H Zhi H Wang L Ren Z Shi H Peng L Cui G Ma X Ye Y Feng C Shen X Zhai C Zhang K Zen N Liu 2010 Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population Mol Biol Rep 37 1 13 20 19283512 10.1007/s11033-009-9482-x 1:CAS:528:DC%2BC3cXisFSrsA%3D%3D
10. Rahimi Z, Felehgari V, Rahimi M, Mozafari H, Yari K, Vaisi-Raygani A, Rezaei M, Malek-Khosravi S, Khazaie H (2011) The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria. Mol Biol Rep 38(3):2117-2123
11. D Kelly G Cockerill M Thompson S Khan NJ Samani IB Squire 2007 Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study Eur Heart J 28 711 718 17339265 10.1093/eurheartj/ehm003 1:CAS:528:DC%2BD2sXlt1Ojt7w%3D (Pubitemid 46439245)
12. H Li H Xu S Liu 1994 Toll-like receptors 4 induces expression of matrix metalloproteinase-9 in human aortic smooth muscle cells Mol Biol Rep 38 1419 1423 10.1007/s11033-010-0246-4
13. GH Gibbons VJ Dzau 1994 The emerging concept of vascular remodelling N Engl J Med 330 1431 1438 8159199 10.1056/NEJM199405193302008 1:STN:280:DyaK2c3htFantA%3D%3D (Pubitemid 24139238)
14. B Ayşegül GH Veysi M Muzaffer D Irfan A Azra K Hulyam 2010 Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter? Mol Biol Rep 38 1469 1474 20845079 10.1007/s11033-010-0253-5
15. ZS Galis JJ Khatri 2002 Matrix metalloproteinases in vascular remodeling and atherogenesis. The good, the bad, and the ugly Circ Res 90 251 262 11861412 1:CAS:528:DC%2BD38Xhs1Wrsb4%3D (Pubitemid 34633925)
16. S Nanni G Melandri R Hanemaaijer V Cervi L Tomasi A Altimari N Van Lent P Tricoci L Bacchi A Branzi 2007 Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms Transl Res 149 3 137 144 17320799 10.1016/j.trsl.2006.09.001 1:CAS:528:DC%2BD2sXitFCisb8%3D (Pubitemid 46275571)
17. IM Loftus AR Naylor S Goodall 2000 Increased matrix metalloproteinase-9 activity in unstable carotid plaques: a potential role in acute plaque disruption Stroke 31 40 47 10625713 10.1161/01.STR.31.1.40 1:CAS:528: DC%2BD3cXmsVGiuw%3D%3D (Pubitemid 30035750)
18. B Zhang S Ye SM Herrmann P Eriksson M de Maat A Evans D Arveiler G Luc F Cambien A Hamsten H Watkins AM Henney 1999 Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis Circulation 99 1788 1794 10199873 1:CAS:528:DyaK1MXislejsrc%3D (Pubitemid 29181405)
19. PJ Pollanen PJ Karhunen J Mikkelsson 2001 Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study Arterioscler Thromb Vasc Biol 21 1446 1450 11557670 10.1161/hq0901.095545 1:CAS:528:DC%2BD3MXntVGku7w%3D (Pubitemid 34219806)
20. B Zhang A Henney P Eriksson A Hamsten H Watkins S Ye 1999 Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1 Hum Genet 105 418 423 10598806 10.1007/s004390051124 1:CAS:528: DC%2BD3cXit1yitA%3D%3D
21. H Kai H Ikeda H Yasukawa 1998 Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes J Am Coll Cardiol 32 368 372 9708462 10.1016/S0735-1097(98)00250-2 1:STN:280:DyaK1cznt1WltQ%3D%3D (Pubitemid 28396484)
22. H Kim S Dalal E Young 2000 Disruption of the myocardial extracellular matrix leads to cardiac dysfunction J Clin Invest 106 857 866 11018073 10.1172/JCI8040 1:CAS:528:DC%2BD3cXntVyiu7k%3D
23. Sambrook J, Russell DW (2001) Preparation and analysis of Eukaryotic genomic DNA. In: Argentine J, Irwin N (eds) Molecular cloning: a laboratory manual, vol 1. Cold spring Harbor Laboratory Press, Cold Spring Harbor (protocol 6.1)
24. D Kleiner W Stetler-Stevenson 1994 Quantitative zymography: detection of picogram quantities of gelatinases Anal Biochem 218 325 329 8074288 10.1006/abio.1994.1186 1:CAS:528:DyaK2cXkslKktbk%3D (Pubitemid 24141631)
25. A Cho MA Reidy 2002 Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury Circ Res 91 845 851 12411400 10.1161/01.RES.0000040420.17366.2E 1:CAS:528:DC%2BD38XotFKjsrk%3D (Pubitemid 35285083)
26. PE Ferrand S Parry M Sammel 2002 A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in Africans Americans Mol Hum Reprod 8 5 494 501 11994547 10.1093/molehr/8.5.494 1:CAS:528:DC%2BD38XkvVGqurY%3D (Pubitemid 34567928)
27. JB Ubbink WJ Hayward Vermaak S Bissbort 1991 Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum J Chromatogr 565 441 446 1874890 10.1016/0378-4347(91)80407-4 1:CAS:528: DyaK3MXit1Crt7w%3D
28. A Vaisi-Raygani Z Rahimi H Entezami H Kharrazi F Bahrhemand H Tavilani M Rezaei A Kiani B Nomanpour T Pourmotabbed 2008 Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran Scand J Clin Lab Invest 68 2 123 129 17852836 10.1080/00365510701576180 1:CAS:528:DC%2BD1cXkt12ntL8%3D (Pubitemid 351481736)
29. S Blankenberg HJ Rupprecht O Poirier C Bickel M Smieja G Hafner J Meyer F Cambien L Tiret AtheroGene Investigators 2003 Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation 107 1579 1585 12668489 10.1161/01.CIR. 0000058700.41738.12 1:CAS:528:DC%2BD3sXit12msLo%3D (Pubitemid 36397324)
30. TL Medley TJ Cole AM Dart CD Gatzka BA Kingwell 2004 Matrix metallaproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression Arterioscler Thromb Vasc Biol 24 1479 1484 15191941 10.1161/01.ATV.0000135656.49158.95 1:CAS:528:DC%2BD2cXmtValurw%3D (Pubitemid 39050444)
31. J Sundstrom JC Evans EJ Benjamin D Levy MG Larson DB Sawyer DA Siwik WS Colucci P Sutherland PWF Wilson RS Vasan 2004 Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study Circulation 109 23 2850 2856 15173025 10.1161/01.CIR.0000129318.79570.84 (Pubitemid 38786446)
32. M Ranucci A Ballotta A Frigiola A Boncilli S Brozzi E Costa RH Mehta 2009 Preoperative homocysteine levels and morbidity and mortality following cardiac surgery Eur Heart J 30 995 1004 19224934 10.1093/eurheartj/ehp015 1:CAS:528:DC%2BD1MXkvFKju7g%3D
33. D Pasali N Marinkovi B Grskovi G Ferencak R Bernat A Stavljeni-Rukavina 2009 C-reactive protein gene polymorphisms affect plasma CRP and homocysteine concentrations in subjects with and without angiographically confirmed coronary artery disease Mol Biol Rep 36 4 775 780 10.1007/s11033-008-9244-1
34. Madani H, Rahimi Z, Manavi-Shad M, Mozafari H, Akramipour R, Vaisi-Raygani A, Rezaei M, Malek-Khosravi S, Shakiba E, Parsian A (2011) Plasma lipids and lipoproteins in children and young adults with major β-thalassemia from western Iran: influence of genotype. Mol Biol Rep 38(4):2573-2578
35. M Ashok Kumar NG Subhashini R SaiBabu A Ramesh KM Cherian C Emmanuel 2010 Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians Mol Biol Rep 37 1 521 527 10.1007/s11033-009-9728-7 1:CAS:528:DC%2BC3cXisFSmsQ%3D%3D
36. S Liang M Pan HH Geng H Chen LQ Gu XT Qin JJ Qian JH Zhu CF Liu 2009 Apolipoprotein E polymorphism in normal Han Chinese population: frequency and effect on lipid parameters Mol Biol Rep 36 6 1251 1256 18600472 10.1007/s11033-008-9305-5 1:CAS:528:DC%2BD1MXmtlOnsLk%3D
37. L Robertson L Grip L Mattsson Hulte J Hulthe O Wiklund 2007 Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention J Internal Medici 262 659 667 10.1111/j.1365-2796.2007.01861.x 1:CAS:528:DC%2BD1cXjs1aluw%3D%3D (Pubitemid 350135190)